|4Jan 5, 3:30 PM ET

Sagent Pharmaceuticals, Inc. 4

4 · Sagent Pharmaceuticals, Inc. · Filed Jan 5, 2016

Insider Transaction Report

Form 4
Period: 2015-12-31
Drake Lorin
VP, Sales and Marketing
Transactions
  • Tax Payment

    Common Stock

    2015-12-31$15.85/sh853$13,52032,529 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION